A citation-based method for searching scientific literature

Reshma Jagsi, Kent A Griffith, Allison W Kurian, Monica Morrow, Ann S Hamilton, John J Graff, Steven J Katz, Sarah T Hawley. J Clin Oncol 2015
Times Cited: 59







List of co-cited articles
362 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
40

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
284
30

Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
69
28

Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer.
Amanda Dawn Gammon, Erin Rothwell, Rebecca Simmons, Jan T Lowery, Lori Ballinger, Deirdre A Hill, Kenneth M Boucher, Anita Yeomans Kinney. J Genet Couns 2011
32
43

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
74
22

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
224
20

Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.
Katarina M Sussner, Lina Jandorf, Hayley S Thompson, Heiddis B Valdimarsdottir. Psychooncology 2013
45
26

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
20

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
84
20

Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
Anita Yeomans Kinney, Amanda Gammon, James Coxworth, Sara E Simonsen, Maritza Arce-Laretta. Genet Med 2010
65
18

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Allison W Kurian, Kent A Griffith, Ann S Hamilton, Kevin C Ward, Monica Morrow, Steven J Katz, Reshma Jagsi. JAMA 2017
70
18

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
836
16

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
101
16

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
D Cragun, D Bonner, J Kim, M R Akbari, S A Narod, A Gomez-Fuego, J D Garcia, S T Vadaparampil, Tuya Pal. Breast Cancer Res Treat 2015
50
20

Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Brian Drohan, Constance A Roche, James C Cusack, Kevin S Hughes. Ann Surg Oncol 2012
57
15

If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.
Charité Ricker, Veronica Lagos, Nancy Feldman, Susan Hiyama, Sue Fuentes, Visanth Kumar, Kelly Gonzalez, Melanie Palomares, Kathleen Blazer, Katrina Lowstuter,[...]. J Genet Couns 2006
43
20


The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey.
Susan T Vadaparampil, Louise Wideroff, Nancy Breen, Edward Trapido. Cancer Epidemiol Biomarkers Prev 2006
56
14

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
628
13

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
51
15

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
62
13

Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
Vanessa B Sheppard, Darren Mays, Thomas LaVeist, Kenneth P Tercyak. J Natl Med Assoc 2013
63
13

Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City.
Katarina M Sussner, Lina Jandorf, Hayley S Thompson, Heiddis B Valdimarsdottir. J Genet Couns 2010
31
25

BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation.
Katarina M Sussner, Tiffany Edwards, Cristina Villagra, M Carina Rodriguez, Hayley S Thompson, Lina Jandorf, Heiddis B Valdimarsdottir. J Genet Couns 2015
32
25



Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.
Kathleen E Malone, Colin B Begg, Robert W Haile, Ake Borg, Patrick Concannon, Lina Tellhed, Shanyan Xue, Sharon Teraoka, Leslie Bernstein, Marinela Capanu,[...]. J Clin Oncol 2010
112
11

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
222
11

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
90
11

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
11

Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors.
Tarsha Jones, Joan S Lockhart, Kari E Mendelsohn-Victor, Debra Duquette, Laurel L Northouse, Sonia A Duffy, Rosemary Donley, Sofia D Merajver, Kara J Milliron, J Scott Roberts,[...]. Am J Prev Med 2016
29
24

Latinas and breast cancer outcomes: population-based sampling, ethnic identity, and acculturation assessment.
Ann S Hamilton, Timothy P Hofer, Sarah T Hawley, Donna Morrell, Meryl Leventhal, Dennis Deapen, Barbara Salem, Steven J Katz. Cancer Epidemiol Biomarkers Prev 2009
76
11

Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Sarah T Hawley, Reshma Jagsi, Monica Morrow, Nancy K Janz, Ann Hamilton, John J Graff, Steven J Katz. JAMA Surg 2014
116
11


Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
11


Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
Amelie G Ramirez, Fabiola E Aparicio-Ting, Sandra San Miguel de Majors, Alexander R Miller. Ethn Dis 2006
34
17

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
155
10

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
333
10

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
10

What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
Inez Adams, Juleen Christopher, Karen Patricia Williams, Vanessa B Sheppard. J Cancer Educ 2015
24
25

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
304
10

Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
75
10

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
202
10

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Julie Dutil, Volha A Golubeva, Alba L Pacheco-Torres, Hector J Diaz-Zabala, Jaime L Matta, Alvaro N Monteiro. Breast Cancer Res Treat 2015
47
12

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Edith A Perez, John A Olson,[...]. N Engl J Med 2015
736
10

Racial and ethnic disparities in awareness of genetic testing for cancer risk.
José A Pagán, Dejun Su, Lifeng Li, Katrina Armstrong, David A Asch. Am J Prev Med 2009
66
10

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Joanne Armstrong, Michele Toscano, Nancy Kotchko, Sue Friedman, Marc D Schwartz, Katherine S Virgo, Kristian Lynch, James E Andrews, Claudia X Aguado Loi, Joseph E Bauer,[...]. JAMA Oncol 2015
79
10

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
138
10

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
132
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.